Recent updates on COVID-19 from Annals of Internal Medicine
A study conducted by researchers from the Geneva University Hospitals has revealed that a significant number of patients diagnosed with COVID-19 continue to experience lingering symptoms months after infection. The study, which is part of Geneva's CoviCare program, was conducted from 18 March to 15 May 2020 and its findings are published in Annals of Internal Medicine.
The survey, which used semistructured telephone interviews at enrollment, 30 to 45 days, and 7 to 9 months from diagnosis, involved 410 patients. The results showed that 39.0% of these patients reported experiencing lingering symptoms 7 months after infection.
Common lingering symptoms included fatigue (20.7%), loss of taste or smell (16.8%), shortness of breath (11.7%), and headache (10.0%).
The study's authors suggest that patients treated for mild to moderate COVID-19 should be informed about the potential for long-term effects. Physicians should also be aware of other causes of symptoms such as fatigue, cognitive and neurologic symptoms, and shortness of breath to avoid misinterpretation.
The editorial in the article "Many COVID-19 Deaths Could Have Been Avoidable" in Annals of Internal Medicine was authored by an expert contributor with numerous publications in this journal. However, the specific author’s name is not provided in the available search results.
For media inquiries, contact HUG Presse at [email protected].
Read also:
- Peptide YY (PYY): Exploring its Role in Appetite Suppression, Intestinal Health, and Cognitive Links
- Toddler Health: Rotavirus Signs, Origins, and Potential Complications
- Digestive issues and heart discomfort: Root causes and associated health conditions
- House Infernos: Deadly Hazards Surpassing the Flames